Sinride VM 2mg/500mg/0.2mg Tablet SR
Marketer
Indoscot Healthcare LLP
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Sinride VM 2mg/500mg/0.2mg Tablet SR
Diabexe Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as anti-diabetic medications. This triple-combination therapy is indicated for adult patients with type 2 diabetes to manage blood glucose. Diabexe Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and increase the risk of complications including kidney disease, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or lactating individuals should consult their physician prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Sinride VM 2mg/500mg/0.2mg Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Sinride VM 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sinride VM 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Sinride VM 2mg/500mg/0.2mg Extended-Release Tablet should be consumed on an empty stomach.
Common Side effects of Sinride VM 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Sinride VM 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sinride VM 2mg/500mg/0.2mg Extended-Release Tablets on an empty stomach.
How Sinride VM 2mg/500mg/0.2mg Tablet SR works:
Sinride VM 2mg/500mg/0.2mg extended-release tablets contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Sinride VM 2mg/500mg/0.2mg SR Tablet ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Sinride VM 2mg/500mg/0.2mg Tablet SR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Prolonged breastfeeding while taking Sinride VM 2mg/500mg/0.2mg SR tablets is likely inadvisable. Preliminary evidence in humans indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney impairment should likely avoid Sinride VM 2mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, this medication is unsuitable for individuals with severe kidney disease.
LiverCAUTION
Exercise caution when prescribing Sinride VM 2mg/500mg/0.2mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose is typically recommended for patients with mild to moderate liver disease; use is contraindicated in those with severe liver dysfunction.
What if you forget to take Sinride VM 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Sinride VM 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sinride VM 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently